These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7894621)
1. Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions. Tamura M; Ono N; Zama A; Kurihara H Noshuyo Byori; 1994; 11(2):173-6. PubMed ID: 7894621 [TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of S-phase cells in human gliomas]. Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117 [TBL] [Abstract][Full Text] [Related]
3. Development of anaplastic changes in low-grade astrocytomas of childhood. Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571 [TBL] [Abstract][Full Text] [Related]
4. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study. Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
7. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923 [TBL] [Abstract][Full Text] [Related]
8. Annexin II marks astrocytic brain tumors of high histologic grade. Roseman BJ; Bollen A; Hsu J; Lamborn K; Israel MA Oncol Res; 1994; 6(12):561-7. PubMed ID: 7787249 [TBL] [Abstract][Full Text] [Related]
9. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature. Marton E; Feletti A; Orvieto E; Longatti P J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and alterations in telomere length in human brain tumors. Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755 [TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions (AgNORs) in astrocytic tumors. Pedal WP; Warzok RW; Hufnagl P; Roth K Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679 [TBL] [Abstract][Full Text] [Related]
12. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639 [TBL] [Abstract][Full Text] [Related]
13. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods. Hsu CY; Ho DM; Yang CF; Chiang H Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of multiple genes in astrocytic gliomas. Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314 [TBL] [Abstract][Full Text] [Related]
15. [Morphological changes in basement membrane associated with endothelial proliferation in astrocytic tumors--an immunohistochemical study of laminin]. Shinoda J; Hirayama H; Araki Y; Andoh T; Sakai N; Yamada H No To Shinkei; 1989 Mar; 41(3):263-71. PubMed ID: 2474310 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres]. Korshunov AG; Sycheva RV Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938 [TBL] [Abstract][Full Text] [Related]
17. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination. Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222 [TBL] [Abstract][Full Text] [Related]
19. Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases. Labrousse F; Daumas-Duport C; Batorski L; Hoshino T J Neurosurg; 1991 Aug; 75(2):202-5. PubMed ID: 1649271 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]